Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

ARTICLE | Finance

Biotech bulls and bears in 2025

Public Markets Preview: Will political uncertainty resolve in biotech’s favor or lead to economically damaging policy?

By Stephen Hansen, Director of Biopharma Intelligence

January 22, 2025 12:57 AM UTC

Just four months ago, investors were convinced that 2025 would be the year that biotech broke free of its macroeconomic shackles, with outperformance of the broader markets driving capital inflows and a further opening up of the IPO market.